US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
Results from Moderna’s early studies of the bird flu shot are expected in the next few weeks. The US government contract is a win for the company, which is looking for new sources of revenue and trying to shake its reliance on the fading market for Covid vaccines.